Individualization of cancer treatment: contribution of OMICs technologies to cancer diagnostic

作者: S Souchelnytskyi , None

DOI: 10.15407/BIOTECH6.04.105

关键词:

摘要: Cancer still kills people. It was easier to send a man in the outer space or Moon, than improve survival of patients having advanced and metastatic cancers. This highlights complexity cancer as disease, which is apparently much higher build launch rocket. Carcinogenic transformation cells accepted main cause [1–4]. defined number changes cell physiology, lead expansion malignant body, corrupting normal ultimately killing person. The key conclusion more 50 years intense studies that collected knowledge has not reached critical mass required find cure against cancer. oncogenes tumor suppressor model been great step forward [1–4], but today clear carcinogenic result interaction hundreds molecules. Out these cancer-promoting genes, RNAs, proteins metabolites many are same they cells. their corrupted activity, mis-localization, misplaced interactions make them tumorpromoting (Fig. 1). confusion only underlined A solution problem proposed by introduction technologies for comprehensive study carcinogenesis. These focused on genomic DNA (genomics), RNAs (transcripUDK 575.113+577.214+612.321

参考文章(55)
S Souchelnytskyi, P Conrotto, Proteomic approaches in biological and medical sciences: principles and applications. Experimental Oncology. ,vol. 30, pp. 171- 180 ,(2008)
Richard W Tothill, Maria A Doyle, Cliff Meldrum, Next-Generation Sequencing for Cancer Diagnostics: a Practical Perspective The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists. ,vol. 32, pp. 177- 195 ,(2011)
Markus Islinger, Christoph Eckerskorn, Alfred Völkl, Free-flow electrophoresis in the proteomic era: A technique in flux ELECTROPHORESIS. ,vol. 31, pp. 1754- 1763 ,(2010) , 10.1002/ELPS.200900771
Barton E. Slatko, Jan Kieleczawa, Jingyue Ju, Andrew F. Gardner, Cynthia L. Hendrickson, Frederick M. Ausubel, “First Generation” Automated DNA Sequencing Technology Current protocols in molecular biology. ,vol. 96, ,(2011) , 10.1002/0471142727.MB0702S96
Matthew B. Nodwell, Stephan A. Sieber, ABPP Methodology: Introduction and Overview Topics in Current Chemistry. ,vol. 324, pp. 1- 41 ,(2011) , 10.1007/128_2011_302
Francesco Gorreta, Vikas Chandhoke, Michael Estep, Luca Del Giacco, Geraldine M. Grant, Amy Van Meter, Alan Christensen, James Cooper, Carleton Garrett, Chahla Naouar, Amanda Fortney, Ali Al-Timimi, Lakshmi Appalla, Jean Donovan, Curtis Jamison, Microarrays in cancer research. Anticancer Research. ,vol. 24, pp. 441- 448 ,(2004)
R.R. Gullapalli, M. Lyons-Weiler, P. Petrosko, R. Dhir, M.J. Becich, W.A. LaFramboise, Clinical Integration of Next-Generation Sequencing Technology Clinics in Laboratory Medicine. ,vol. 32, pp. 585- 599 ,(2012) , 10.1016/J.CLL.2012.07.005
Christine Desmedt, Thierry Voet, Christos Sotiriou, Peter J. Campbell, Next generation sequencing in breast cancer: first take home messages Current Opinion in Oncology. ,vol. 24, pp. 597- 604 ,(2012) , 10.1097/CCO.0B013E328359554E
Fang Xie, Richard D. Smith, Yufeng Shen, Advanced proteomic liquid chromatography Journal of Chromatography A. ,vol. 1261, pp. 78- 90 ,(2012) , 10.1016/J.CHROMA.2012.06.098